Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients.
Gramenzi A, Tedeschi S, Cantarini MC, Erroi V, Tumietto F, Attard L, Calza L, Foschi FG, Caraceni P, Pavoni M, Cucchetti A, Bernardi M, Viale P, Verucchi G, Trevisani F. Gramenzi A, et al. Among authors: trevisani f. Dig Liver Dis. 2013 Jun;45(6):516-22. doi: 10.1016/j.dld.2012.12.010. Epub 2013 Jan 16. Dig Liver Dis. 2013. PMID: 23332770
Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II study.
Brandi G, de Rosa F, Agostini V, di Girolamo S, Andreone P, Bolondi L, Serra C, Sama C, Golfieri R, Gramenzi A, Cucchetti A, Pinna AD, Trevisani F, Biasco G; Italian Liver Cancer (ITA.LI.CA) Group. Brandi G, et al. Among authors: trevisani f. Oncologist. 2013;18(12):1256-7. doi: 10.1634/theoncologist.2013-0093. Epub 2013 Nov 13. Oncologist. 2013. PMID: 24232581 Free PMC article. Clinical Trial.
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis.
Gramenzi A, Golfieri R, Mosconi C, Cappelli A, Granito A, Cucchetti A, Marinelli S, Pettinato C, Erroi V, Fiumana S, Bolondi L, Bernardi M, Trevisani F; BLOG (Bologna Liver Oncology Group). Gramenzi A, et al. Among authors: trevisani f. Liver Int. 2015 Mar;35(3):1036-47. doi: 10.1111/liv.12574. Epub 2014 May 20. Liver Int. 2015. PMID: 24750853
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.
Golfieri R, Giampalma E, Renzulli M, Cioni R, Bargellini I, Bartolozzi C, Breatta AD, Gandini G, Nani R, Gasparini D, Cucchetti A, Bolondi L, Trevisani F; PRECISION ITALIA STUDY GROUP. Golfieri R, et al. Among authors: trevisani f. Br J Cancer. 2014 Jul 15;111(2):255-64. doi: 10.1038/bjc.2014.199. Epub 2014 Jun 17. Br J Cancer. 2014. PMID: 24937669 Free PMC article. Clinical Trial.
Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma.
Golfieri R, Mosconi C, Cappelli A, Giampalma E, Galaverni MC, Pettinato C, Renzulli M, Monari F, Angelelli B, Pini P, Terzi E, Ascanio S, Garzillo G, Piscaglia F, Bolondi L, Trevisani F. Golfieri R, et al. Among authors: trevisani f. Future Oncol. 2015;11(23):3133-42. doi: 10.2217/fon.15.267. Epub 2015 Oct 15. Future Oncol. 2015. PMID: 26467398
372 results